Doctor Pedro Antonio Sánchez Mesa, MD, DHC

Casa
Colombia
Bogotá
Doctor Pedro Antonio Sánchez Mesa, MD, DHC

Información de contacto, mapa y direcciones, formulario de contacto, horario de apertura, servicios, puntuaciones, fotos, videos y anuncios de Doctor Pedro Antonio Sánchez Mesa, MD, DHC, Ortopedista, Calle 145 No. 91-19 L-10-103 Consultorio 301 PBX: 6016923370 Ext. 10-02, Bogotá.

Cirujano de Trauma Ortopédico | Reconstrucción y Reemplazo de Cadera y Rodilla | Ortopedia Pediátrica | Pionero en Ortopedia Regenerativa y Traslacional Celular y Acelular; Experto en Células Madre, Orto-biológicos| Presidente, SIISDET

14/07/2026

How Can We Promote Osseointegration and Preserve Prosthetic Fixation ?

For many years, the success of total hip and knee arthroplasty was primarily attributed to implant design and surgical technique. Today, we know that the biological quality of the host bone is also a major determinant of implant longevity.
Concepts such as Periprosthetic Bone Preservation and Orthogeriatric Optimization are reshaping the paradigm: the long term survival of an arthroplasty begins before the patient enters the operating room. Within this context, I propose Biological Optimization of Arthroplasty (BOA), which integrates these principles into a systematic strategy for optimizing the patient’s biological status.
Assessing bone health, obtaining DXA scans in at-risk patients, correcting vitamin D deficiency, optimizing mineral metabolism, and identifying osteoporosis in a timely manner are interventions that should be incorporated into preoperative optimization. When clinically indicated, pharmacologic treatment with teriparatide, denosumab, or zoledronic acid, together with calcium and vitamin D supplementation when appropriate, represents a strategy to preserve periprosthetic bone stock.
The goal is not merely to achieve stable initial fixation. We also aim to preserve bone surrounding the implant, reduce periprosthetic bone loss, decrease the risk of periprosthetic fractures, help reduce the risk of aseptic loosening, and ultimately prolong the functional longevity of the arthroplasty.
Today, arthroplasty should be understood as the integration of biomaterials engineering, surgical precision, biomechanics, bone biology, mineral metabolism, rehabilitation, evidence based regenerative medicine, and precision medicine.
As a reconstructive hip and knee arthroplasty surgeon, I believe we must evolve toward a new paradigm: replacing a joint is no longer enough; we must also optimize the patient’s biology to preserve the bone that will maintain stable and durable implant fixation for many years.

I am Dr. Pedro Antonio Sánchez Mesa, MD, PhD(c), DHC (x4). I would be interested in hearing your perspective. Do you agree with this approach?

13/07/2026

Tengo el honor de participar como conferencista en el XV Congreso Internacional de Dolor y Medicina Regenerativa – © (15 th International Congress on Pain and Regenerative Medicine – ® 2026) “Innovación y Tecnologías de Avanzada Multisistemas – Rompiendo Paradigmas”, un espacio donde compartiremos los avances más recientes en medicina regenerativa, ortopedia, tratamiento del dolor y tecnologías de avanzada aplicadas a la práctica clínica.
Durante mi participación presentaré mi experiencia clínica - quirúrgica e investigativa, así como estrategias innovadoras orientadas a mejorar los resultados en pacientes con patologías osteoarticulares, siempre con un enfoque basado en evidencia y en la medicina traslacional.
Será una excelente oportunidad para intercambiar conocimientos con colegas, investigadores y profesionales de la salud de 32 países participantes, fortaleciendo la colaboración académica y el desarrollo de nuevas soluciones para nuestros pacientes.
Nos vemos en📍 Medellín, Colombia
📅 25 al 28 de noviembre de 2026

Los invito a acompañarnos y ser parte de este importante congreso internacional.

Soy el Dr. Pedro Antonio Sánchez Mesa, MD, PhD, DHC (x4), Cirujano Oropedista y Traumatólogo, Cirugía Reconstructiva y del Reemplazo Articular de Cadera y Rodilla, Pionero en Ortopedia Regenerativa y Traslacional.

08/07/2026

Which biomaterial would you choose for a patient ≤55 years old who is highly active or has documented hypersensitivity to nickel, cobalt, or chromium?
The answer should not be based on personal preference, market trends, or commercial strategies. It should be grounded in biomechanics, biomaterials science, and evidence based medicine.
In total hip arthroplasty, BIOLOX delta represents one of the most significant advances in bearing surfaces. It is a next generation ceramic matrix composite (CMC) composed primarily of an alumina matrix reinforced with zirconia and other stabilizing oxides, engineered to provide high resistance to fracture and crack propagation, exceptionally low wear, and excellent biocompatibility. It also represents a valuable option for patients with documented metal hypersensitivity. When combined with robotic assisted or navigation platforms such as Mako SmartRobotics, ROSA Hip, or VELYS Hip Navigation, it may contribute to more precise acetabular component positioning and restoration of femoral offset and limb length.
In total knee arthroplasty, the high impact, compressive, and torsional loads prevent the routine use of monolithic ceramics. In this setting, Oxinium consists of a zirconium and niobium alloy with a ceramicized zirconium oxide surface, combining the hardness and wear resistance of a ceramic surface with the toughness of a metallic substrate while reducing metal ion release compared with conventional cobalt-chromium alloys. Robotic assisted systems such as CORI may improve the accuracy of surgical planning and component positioning.
Excellence in reconstructive joint surgery is not achieved by implanting the most sophisticated biomaterial or technology, but by integrating biomechanics, biomaterials engineering, technology assisted surgery, and the best available scientific evidence to select the right implant for the right patient.
I am Dr. Pedro Antonio Sánchez Mesa, MD, PhD, DHC (x4), Orthopedic Joint Replacement Surgeon.

05/07/2026

Did you know that the bone cement used in hip and knee arthroplasty is not always the same? As a reconstructive hip and knee arthroplasty surgeon, this is one of the questions I am most frequently asked by both my patients and trainees.
Bone cement is primarily composed of polymethyl methacrylate (PMMA). Rather than acting as an adhesive, it functions as a mechanical grout, creating a stable interface between the implant and bone to achieve durable fixation and more homogeneous load distribution.
Bone cements are classified as plain cement or antibiotic loaded bone cement (ALBC). They also differ in viscosity, polymerization time, and handling characteristics. High viscosity cements are commonly used for direct manual application, particularly in total knee arthroplasty, whereas low and medium viscosity cements facilitate injection and adequate cement pe*******on within the femoral canal, especially during total hip arthroplasty.
Current evidence and international consensus statements do not support the routine use of ALBC in every patient. Instead, its use should be individualized, particularly in patients at increased risk of periprosthetic joint infection and in selected revision procedures.
The antibiotics most commonly incorporated into PMMA are gentamicin and tobramycin. In revision surgery for periprosthetic joint infection, the combinations gentamicin plus vancomycin and tobramycin plus vancomycin are among the most widely supported in the literature.
Although there is no bone cement designed exclusively for the hip or the knee, cement selection should be based on the joint being treated, surgical technique, implant design, bone quality, and when infection is present the causative organism and its antimicrobial susceptibility profile.
In reconstructive arthroplasty, bone cement selection should always be guided by the best available scientific evidence, as every decision can directly influence implant longevity and long term functional outcomes.
I am Dr. Pedro Antonio Sánchez Mesa, MD, PhD, DHC (×4), Orthopedic Surgeon specializing in Reconstructive Hip and Knee Arthroplasty.

04/07/2026

It is a true honor to participate as Speaker and Chief Debate Chair at the 30th ISRM© -International Meeting of Specialists in Regenerative Medicine, an international scientific forum bringing together leading experts from 31 countries to discuss the innovations transforming Regenerative Medicine, Tissue Engineering, Translational Medicine, Longevity & Healthy Aging, Aesthetic Medicine, Oncology, Pain Medicine, and advanced musculoskeletal care.
This prestigious meeting is held during the 15th International Congress on Pain and Regenerative Medicine -ICPRM© (SIISDET® 2026) under the theme “Advanced Multisystem Innovation & Technologies, Breaking Paradigms.” Physicians, surgeons, interventional specialists, researchers, university professors, and healthcare professionals will share the latest evidence and clinical advances in cellular and acellular therapies, orthobiologics, artificial intelligence, robotics, biomedical engineering, microbiology, and image-guided interventions for pain management, tissue repair, and functional reconstruction.
As Chief Debate Chair, I will have the privilege of leading high-level scientific discussions designed to promote critical thinking, international collaboration, and evidence-based consensus on the preparation, optimization, preservation, and clinical application of regenerative therapies across multiple scientific disciplines.
This global event is organized by Siisdet- Sociedad Internacional Investigación Salud, Desarrollo Empresarial (International Society for Research, Health, Business Development and Technologies®), an international organization founded in 2003 with a presence in more than 56 countries, dedicated to scientific research, medical education, technological innovation, and global academic collaboration.
📅 November 27, 2026
📍 Hotel Dann Carlton, El Poblado, Medellín, Colombia
I look forward to reconnecting with colleagues and friends from around the world as we continue advancing the future of regenerative medicine through science, innovation, education, and international collaboration.
I am Dr. Pedro Antonio Sánchez Mesa, MD, PhD(c), DHC (x4)….. See you in Medellín!

03/07/2026

One of the primary goals of modern total hip arthroplasty is to provide a stable joint with a wide range of motion while minimizing the risk of dislocation. One of the most important innovations in reconstructive hip surgery is the Dual Mobility (DM) acetabular cup.
As a reconstructive hip and joint replacement surgeon, I consider this technology a major advance in preventing prosthetic instability. Its design incorporates two articulating interfaces: one between the femoral head and the polyethylene liner, and another between the liner and the metal acetabular shell. This biomechanical concept increases functional range of motion and jump distance, significantly reducing the risk of dislocation.
Its main advantages include greater hip stability, a lower risk of dislocation, improved safety during daily activities, and fewer revision surgeries for instability. Multiple clinical series have reported dislocation rates of less than 1% when appropriately indicated.
Like any technology, it has limitations. The dual articulating interfaces create a different polyethylene wear pattern. Although highly cross-linked polyethylene has significantly improved durability, long-term wear remains a consideration. In addition, intraprosthetic dislocation is a rare complication, although its incidence has declined substantially with contemporary implant designs.
Does every patient need a Dual Mobility cup? No. There is no universal prosthesis. Implant selection must be individualized according to each patient’s anatomy, biomechanics, activity level, and risk factors.
In my practice, I recommend it primarily for patients with Parkinson’s disease, dementia, neuromuscular disorders, spinopelvic abnormalities, previous spine surgery, femoral neck fractures, obesity, or a history of hip instability or dislocation. In young, highly active patients, there is no consensus against its use. However, when the risk of instability is low, some surgeons prefer conventional bearings, whereas others, including myself, choose Dual Mobility when greater stability is clinically justified.

I am Dr. Pedro Antonio Sánchez Mesa, MD, PhD, DHC (x4).

02/07/2026

¿Tiene una alergia conocida a algún metal antes de considerar un reemplazo total de rodilla?
Como Cirujano Reconstructivo de Cadera y Rodilla, una de las preguntas que con mayor frecuencia recibo es si todas las prótesis de rodilla son iguales. La respuesta es No.
En la 1ra columna presento una prótesis convencional de aleación de cobalto-cromo-molibdeno (CoCrMo). Son implantes con excelentes resultados clínicos a largo plazo; sin embargo, como toda aleación metálica sin recubrimiento, puede liberar pequeñas cantidades de iones de cobalto, cromo y níquel con el paso del tiempo. En la mayoría de los pacientes esto no representa un problema clínico, pero puede ser relevante en personas con hipersensibilidad documentada a estos metales.
En la 2da columna muestro el Nitruro de Titanio (TiN), un recubrimiento cerámico de primera generación aplicado mediante tecnología avanzada de Deposición Física de V***r (PVD). Este recubrimiento crea una barrera inerte, ultradura y altamente biocompatible que disminuye la corrosión, reduce la liberación de iones metálicos y reduce la fricción y el desgaste del polietileno. Por ello constituye una excelente alternativa en pacientes con sensibilidad al níquel, cobalto o cromo.
En la 3ra columna presento el Nitruro de Titanio y Niobio (TiNbN), una evolución tecnológica del TiN. La incorporación de niobio mejora la estabilidad química del recubrimiento, aumenta su resistencia frente a microfisuras y ofrece un comportamiento tribológico ligeramente superior en estudios de laboratorio, manteniendo una excelente biocompatibilidad y propiedades hipoalergénicas.
En mi práctica, la selección del implante nunca se basa en elegir la tecnología más nueva, sino la tecnología más adecuada para cada paciente, considerando su anatomía, calidad ósea, nivel de actividad, antecedentes médicos y, cuando existe, la hipersensibilidad a los metales.
La mejor prótesis no es la más costosa ni la más moderna; es la que ofrece la mejor indicación para cada paciente, respaldada por la evidencia científica.
Soy el Dr. Pedro Antonio Sánchez Mesa, MD, PhD, DHC (x4) Ortopedista y Traumatólogo. Especialista en Cadera y , Bogotá, Col.

01/07/2026

Paciente que nos visita desde Miami., comparte su experiencia. Innovacion en cadera y rodilla, recupera la movilidad preservando la articulacion. Bogota - Colombia PBX : +576016923370, pacientes fuera de la ciudad o el pais teleconsulta inicial WhatsApp +573142448344 mi equipo Multidisciolinario y yo estamos para servirle.

01/07/2026

Not every patient requiring total hip arthroplasty needs the same femoral stem. Selecting the appropriate implant begins with understanding the patient’s anatomy rather than adapting the patient’s anatomy to the implant. This principle represents one of the fundamental pillars of personalized hip reconstruction.

The calcar-guided short stem has become an excellent option in carefully selected patients because it combines bone preservation with individualized biomechanical reconstruction. Its versatility across a broad spectrum of proximal femoral morphologies, particularly different neck-shaft (CCD) angles, allows precise restoration of femoral offset, leg length, and native hip biomechanics while simultaneously promoting physiological load transfer to the proximal femur.

When I implant it using my Modified Indirect Lateral Approach (MILA), this philosophy extends beyond simply selecting the implant. The tissue-preserving characteristics of MILA streamline the procedure and help minimize surgical morbidity by preserving the abductor mechanism, reducing bone resection, and maintaining the native biomechanics of the surrounding soft tissues. The combination of a calcar-guided short stem with a tissue-preserving surgical approach creates a synergistic effect that promotes early functional recovery without compromising implant stability or biomechanical reconstruction.

Hip arthroplasty is no longer simply about replacing a joint. It is about restoring anatomy, preserving biology, respecting the soft tissues, and reproducing physiological biomechanics to achieve durable long-term outcomes.

Dr. Pedro Antonio Sánchez Mesa, MD, PhD, DHC (x4)
Orthopaedic Hip Reconstruction Surgeon

29/06/2026

One of the most common misconceptions is to assume that all surgical robots are the same. In reality, each platform has been developed with a different technological philosophy, and understanding these differences is essential for selecting the most appropriate surgical tool.
In hip and knee arthroplasty, we can identify three technological concepts. Intelligent navigation systems, such as CORI, provide real time anatomical information that helps optimize implant alignment and positioning throughout the procedure. Image guided systems, represented by ROSA, integrate surgical planning and anatomical references to assist in performing bone resections with high precision. Finally, haptic robotic arm systems, such as MAKO SmartRobotics, combine three dimensional planning based on computed tomography with virtual boundaries that restrict the instrument’s action to the preplanned surgical volume.
It is important to emphasize that none of these systems replaces our judgment, our experience, or our decision-making. Robotics is an assistive technology whose purpose is to increase the precision and reproducibility of the surgical technique.
High quality scientific evidence demonstrates that robotic assisted surgery improves implant positioning accuracy and reduces alignment errors compared with conventional techniques. However, based on both my experience and the current medical literature, I have not found compelling evidence demonstrating the long term clinical superiority of one robotic platform over another.
As a reconstructive surgeon, my commitment has always been to understand the strengths, limitations, and indications of each technology in order to select the most appropriate option according to each patient’s anatomy, pathology, and individual needs. Innovation only achieves its true value when it is supported by scientific knowledge and rigorous surgical ex*****on.
I am Dr. Pedro Antonio Sánchez Mesa, MD, PhD, DHC (x4).

Dirección

Calle 145 No. 91-19 L-10-103 Consultorio 301 PBX: 6016923370 Ext. 10-02
Bogotá
11001000

Teléfono

+57-3142448344

Página web

https://twitter.com/DrPasm

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Doctor Pedro Antonio Sánchez Mesa, MD, DHC publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.